Thursday, July 03, 2014
Political Mayhem Thursday: Mitt Romney for Drug Czar!
That's exactly what I am proposing in today's Detroit News. And yes, I'm serious. The paper's version was abridged for space (that happens); here is the complete version:
In a series of public appearances,
Detroit native Mitt Romney has planted the idea that he might run for
president again in 2016. He should resist the idea; that day has
passed. Instead, his experience and passion should be applied
to public service in a different way: The Mitt Romney who founded Bain
Capital and saved the Utah Winter Olympics should be the next Drug
Czar, and use his financial acumen to destroy narcotics businesses
without mass incarceration.
In the run-up to the 2012 presidential
election, Mitt Romney was celebrated (by Republicans) and eviscerated
(by Democrats) for his vocation: building up and tearing down
businesses. Regardless of how one views the social utility
of this enterprise, no one can dispute that Romney is a smart,
passionate, well-educated man who loves public service and was very good
at what he did while working for Bain Capital.
Romney’s availability matches up with a
special moment for narcotics policy. There is a broad right-left
consensus that the stale tactics of the War on Drugs failed miserably.
It wasted billions of dollars in taxpayer money while
failing to limit drug use. Meanwhile, millions of Americans went to
prison, and a disproportionate number of them were black thanks to harsh
new laws focused on crack cocaine. Federalism was trampled as Big
Government took over state functions to ineffectively
battle street crime. There was something to offend everyone.
The shape of our future (and Romney’s) may
be embedded in our own history. In the 1980’s, crack was one of two
public health crises that ran side-by-side along parallel tracks. The
other, of course, was AIDS. At first, both
were seen as problems caused by the moral failings of disfavored
minorities: the media and others linked the rise of AIDS to the
promiscuity of some gay men, and crack was blamed on African-Americans’
supposed affinity for that drug. Both of these conclusions
were, in some measure, wrong, but these perceptions drove corresponding
moral crusades. Then, in 1986, the paths diverged. A respected
Republican and Reagan appointee, Surgeon General C. Everett Koop, shamed
the nation into addressing AIDS as a medical problem
rather than a moral scourge. The key line in his epic report on AIDS
argued that “It is time to put self-defeating attitudes aside and
recognize that we are fighting a disease, not people.”
Since illegal narcotics is a business
within a market, a modern C. Everett Koop addressing that task should be
a businessperson. Fittingly, Romney’s work at Bain Capital focused on
the part of the narcotics business we have not
systemically attacked—cash flow. Primarily, we have fought narcotics
by attacking labor (through arrest and incarceration), profits (through
forfeitures of drug dealers’ homes and cars), and product (through drug
seizures). These are precisely the factors
Romney discounted at Bain, where he cared much more about evaluating a
company’s cash flow in analyzing its suitability as a target. After
all, profit, labor, and product can all be replaced so long as there is
cash flow, and it was cash flow that promised
Bain the possibility of debt being paid off over time. But if cash
flow and credit are cut off (and drug networks don’t have access to
traditional credit), the business will fail. If given a chance to
de-construct narcotics businesses Romney’s purpose would
be different, but his focus the same: Take the money, because that is
what matters.
Finally, Romney-as-Drug Czar would not be
deterred by the complexity of international financial networks as he set
out to disrupt the cash flow systems of narcotics businesses. This is a
man who lives within those very networks,
after all. In the 2012 campaign, he was harshly criticized for the
complexity of his own finances, which involved wholly owned corporations
in Bermuda, no fewer than 12 different funds in the Cayman Islands,
secretive Swiss bank accounts, and other devices
which required his 2010 tax return to include 55 pages just to describe
the transactions with foreign entities in that one year. While a
comprehensive understanding of such complex cash flows may have hurt
Romney in the last campaign, they would be a striking
asset if set to the task of curtailing the flow of drug money back to
wholesalers and suppliers. This is not a guy who is scared of tangled
financial puzzles.
We have never had a C. Everett Koop for
narcotics, but it’s not too late to fix that mistake. We can no longer
afford to fill our prisons, exacerbate racial tensions, and congratulate
ourselves when no progress is made. With
the War on Drugs being dismantled, we effectively have a do-over on
policy and tactics. The new ideas should come from and be implemented
by people like Romney—people who know business the way that Koop knew
medicine. After all, the harshest criticism of
Romney’s work at Bain Capital was that he sometimes ruthlessly
dismantled and bankrupted businesses. Isn’t that exactly what we want
someone to do to the organizations which import cocaine, trade in
methmphetamine, and wholesale death in the form of heroin?